Ategrity ASIC 深 沪
等待开盘 09-23 09:30:00 美东时间
27.02
-0.050
-0.18%
华盛通- 最 高27.47
- 今 开27.32
- 成交量 5.70万股
- 最 低 26.5798
- 昨 收 27.07
- 总市值 12.95亿
- 52周最高 29.00
- 市盈率 静 16.88
- 换手率 0.12%
- 52周最低 16.35
- 委 比 0.00%
- 总股本 4792.69万
- 历史最高 29.00
- 量 比 0.66
- 振 幅 3.29%
- 历史最低 16.35
- 每 手 1
- 风险率 2.82%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Top 10 small-cap financial stocks boast A+ in momentum grade
Small-cap financial stocks have delivered robust gains in the year so far, with the top ten names earning A+ Momentum Grades that indicate stronger price performance trends relative to sector peers. S...
09-17 23:50
Ategrity Extends Chief Underwriting Officer’s Employment Agreement
Ategrity Specialty Holdings LLC ( ($ASIC) ) has issued an announcement. On Sept...
09-05 05:28
美股大行评级 | 最高400美元！亚马逊绩后获11家大行上调目标价；苹果绩后评级分歧大！3家上调，3家下调；德康医疗、万事达、神经分泌生物科学获多家大行上调目标价
今日重点评级关注：TD Cowen：维持加拿大鹅"买入"评级，目标价从13美元升至18美元；瑞银：维持吉登运动服"买入"评级，目标价从110美元升至111美元
08-03 11:38
Citigroup Maintains Neutral on Ategrity Specialty, Raises Price Target to $28.5
Citigroup analyst Matthew Herrmann maintains Ategrity Specialty (NYSE:ASIC) with a Neutral and raises the price target from $27 to $28.5.
08-01 04:29
Ategrity Specialty Q2 Adj. EPS $0.67 Beats $0.53 Estimate, Sales $148.484M Beat $134.250M Estimate
Ategrity Specialty (NYSE:ASIC) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.53 by 26.42 percent. This is a 63.41 percent increase over earnings of $0.41 per share from the same period last year. The company reported quarterly sales of $148.484 millio...
07-30 04:13
美股大行评级 | 伯恩斯坦上调Robinhood目标价从130美元升至160美元；纽约梅隆银行、Datadog、五三银行、旅行者财产险集团获多家机构上调评级
今日重点评级关注：Needham：维持Immuneering"买入"评级，目标价从11美元升至18美元；富瑞：维持塞德斯医疗"买入"评级，目标价从90美元升至100美元
07-21 11:36
JP Morgan Maintains Overweight on Ategrity Specialty, Raises Price Target to $29
JP Morgan analyst Pablo Singzon maintains Ategrity Specialty (NYSE:ASIC) with a Overweight and raises the price target from $27 to $29.
07-20 22:37
美股大行评级 | 潜在涨幅246.92%！HC Wainwright & Co.上调Rockwell Medical(RMTI)目标价至20美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Rockwell Medical"买入"评级，目标价从2美元升至20美元；Canaccord Genuity：维持创力"买入"评级，目标价从10.5美元升至11美元
07-10 17:36
